PER 1.23% 8.0¢ percheron therapeutics limited

Ann: US FDA Type C Meeting for ATL1102 in DMD, page-69

  1. 841 Posts.
    lightbulb Created with Sketch. 755
    I believe we are already receiving expedited pathways providing regulatory streamlining mechanisms due to ODD and RPDD.
    I am not aware at this time that we have applied for Fast Track.
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.